Kindbody brings genetic testing in-house with the launch of Kindlabs

Leading network of fertility clinics and family building benefit provider offerings
Genetic testing as part of its seamless end-to-end care delivery model

NEW YORK, June 28, 2023 /PRNewswire/ — Very kind, a leading fertility clinic network and provider of family-building benefits to employers, today announced the launch of Kindlabs, its in-house genetic testing division. The addition of Kindlabs incorporates genomics into the company’s vertically integrated end-to-end model, delivering a seamless continuum of care to Kindbody patients. Kindlabs operates its 8,000 square foot state-of-the-art reference laboratory at Secaucus, New Jerseyunder the guidance of dr. Amber CooperKindbody’s Chief Medical Officer for Genomics and Laboratory Sciences, e Manuel ViottiPhD, HCLD, Vice President of Preimplantation Genetic Testing (PGT) and Clinical Laboratory Director.

Dr. Angeline BeltsosCEO, Clinical, at Kindbody, said, “At the heart of Kindbody’s mission is to help build healthy families for our patients. The addition of Kindlabs combines industry-leading technology and expertise with rigorous quality standards, to maximize the possibilities of our patients to achieve a successful pregnancy and bring home a healthy baby.”

Kindlabs offers a verticalized genetic testing platform, from wet lab chemistry to software and bioinformatics, providing comprehensive, medical-grade genetic testing at prices that help democratize access to genomic information. Kindlabs is certified by the Clinical Laboratory Improvement Amendments (CLIA) and enrolled in the College of American Pathologists (CAP) accreditation program, which is widely recognized as the gold standard for molecular diagnostics, ensuring the most accurate and reliable results. Prior to the launch of Kindlabs, Kindbody outsourced preimplantation genetic testing.

Dr. Amber Cooper is an internationally recognized expert in ovarian genomics and ageing. She is dual certified in obstetrics and gynecology, reproductive endocrinology and infertility. In addition to Kindbody, Dr. Cooper holds academic roles as an Associate Professor, Department of Obstetrics and Gynecology, at Wayne State University School of Medicine, and as Adjunct Assistant Professor in the Department of Obstetrics, Gynecology and Women’s Health at St. Louis University. She was the principal investigator or participated in a number of clinical studies and trials supported by the National Institutes of Health (NIH) and other institutions addressing genomics, ovarian aging, and environmental impact on reproduction and genetics. She is a widely published author of peer-reviewed scientific publications on the topics of fertility and women’s health.

Dr. Manuel Viotti is a reproductive molecular geneticist and one of the world’s leading experts in preimplantation genetic testing. In addition to his role in Kindbody, he has a tenure as a senior scientist at the Zouves Foundation for Reproductive Medicine. He is director of the Preimplantation Genetic Diagnosis International Society (PGDIS), board member of the American Society for Reproductive Medicine (ASRM) PGT-SIG and is the founder and officer of the International Registry of Mosaic Embryo Transfers (IRMET). . He is the lead author of numerous peer-reviewed scientific publications in the fields of embryology and genetics and is recognized as a leading authority on embryonic mosaicism.

“Under Dr. Viotti’s visionary leadership, our dedicated scientific team has made great strides in advancing genomic sequencing analysis for the benefit of patients,” said Dr. Amber Cooper. “Dr. Viotti’s instrumental role in leading the development of Kindlabs has positioned Kindbody as an industry leader. Together, our team is revolutionizing genomic testing, delivering valuable improvements that positively impact patients’ lives.”

Kindbody’s clinically managed program covers the full spectrum of reproductive health, including female and male fertility, which includes fertility assessments and education, fertility preservation, genetic testing, in vitro fertilization (IVF), donation and surrogacy services and adoption, as well as a full continuum of reproductive care including physical, mental and emotional support.

Kindbody owns and operates 32 unique clinics across the United States in Arkansas, California, Colorado, District of ColombiaGeorgia, Illinois, Maryland, Michigan, Missouri, New Jersey, New York, Texas, WashingtonAND Wisconsin. To make an appointment, visit Employers who would like to learn more about how Kindbody delivers the best patient experience and outcomes while reducing healthcare costs can contact [email protected].

About Kindbody

Kindbody is a leading network of fertility clinics and a global provider of family-building benefits to employers offering the full spectrum of reproductive care from preconception to postpartum through menopause. Kindbody is the trusted provider of fertility benefits to 112 major employers, covering over 2.4 million lives. Many thousands more receive their fertility care directly from Kindbody across the country at exclusive clinics, mobile clinics and partner clinics. As a fertility benefits provider, technology platform, and direct provider of care, Kindbody offers a seamless, integrated experience with superior health outcomes at lower cost, making fertility care more affordable and accessible to all . Kindbody raised 315 million dollars in funding from major investors including Perceptive Advisors, Morgan Health by JP Morgan Chase, GV (formerly Google Ventures), RRE Ventures, Claritas Health Ventures, Rock Springs Capital, Distributed Ventures, Whatif Ventures and TQ Ventures. Visit and follow us Instagram, ChirpingAND LinkedIn.

SOURCE Very kind

#Kindbody #brings #genetic #testing #inhouse #launch #Kindlabs
Image Source :

Leave a Comment